What Viking Global Investors LP changed, 2013 to 2026
53 quarterly 13F filings, from Q2 2013 to Q2 2026, each read from the filing itself. A quarter is compared only with the quarter before it, so a quarter with no filing is a gap in the record, not a sale.
Reported book
$35.1bn
$18.0bn at Q2 2013
Positions
90
59 at Q2 2013
Top ten weight
36%
50% at Q2 2013
Typical quarterly turnover
about 28%
Estimated from share changes
- Q2 2013: $18.0bn
- Q3 2013: $18.1bn
- Q4 2013: $21.4bn
- Q1 2014: $23.8bn
- Q2 2014: $22.9bn
- Q3 2014: $24.9bn
- Q4 2014: $21.8bn
- Q1 2015: $25.8bn
- Q2 2015: $26.5bn
- Q3 2015: $26.1bn
- Q4 2015: $26.5bn
- Q1 2016: $22.7bn
- Q2 2016: $23.5bn
- Q3 2016: $23.2bn
- Q4 2016: $22.0bn
- Q1 2017: $22.6bn
- Q2 2017: $14.8bn
- Q3 2017: $15.4bn
- Q4 2017: $16.3bn
- Q1 2018: $16.6bn
- Q2 2018: $17.5bn
- Q3 2018: $18.1bn
- Q4 2018: $17.6bn
- Q1 2019: $17.4bn
- Q2 2019: $22.3bn
- Q3 2019: $19.2bn
- Q4 2019: $21.4bn
- Q1 2020: $19.2bn
- Q2 2020: $23.1bn
- Q3 2020: $27.7bn
- Q4 2020: $36.4bn
- Q1 2021: $33.6bn
- Q2 2021: $33.0bn
- Q3 2021: $36.5bn
- Q4 2021: $34.7bn
- Q1 2022: $24.7bn
- Q2 2022: $21.9bn
- Q3 2022: $21.7bn
- Q4 2022: $20.0bn
- Q1 2023: $21.3bn
- Q2 2023: $24.4bn
- Q3 2023: $24.6bn
- Q4 2023: $27.3bn
- Q1 2024: $26.9bn
- Q2 2024: $26.0bn
- Q3 2024: $27.4bn
- Q4 2024: $30.9bn
- Q1 2025: $31.5bn
- Q2 2025: $34.6bn
- Q3 2025: $38.5bn
- Q4 2025: $37.7bn
- Q1 2026: $35.7bn
- Q2 2026: $35.1bn
- Q2 2013: 50%
- Q3 2013: 47%
- Q4 2013: 43%
- Q1 2014: 48%
- Q2 2014: 48%
- Q3 2014: 43%
- Q4 2014: 46%
- Q1 2015: 45%
- Q2 2015: 47%
- Q3 2015: 49%
- Q4 2015: 52%
- Q1 2016: 62%
- Q2 2016: 55%
- Q3 2016: 53%
- Q4 2016: 54%
- Q1 2017: 56%
- Q2 2017: 55%
- Q3 2017: 52%
- Q4 2017: 48%
- Q1 2018: 51%
- Q2 2018: 52%
- Q3 2018: 57%
- Q4 2018: 55%
- Q1 2019: 51%
- Q2 2019: 54%
- Q3 2019: 51%
- Q4 2019: 50%
- Q1 2020: 48%
- Q2 2020: 44%
- Q3 2020: 41%
- Q4 2020: 39%
- Q1 2021: 37%
- Q2 2021: 37%
- Q3 2021: 39%
- Q4 2021: 37%
- Q1 2022: 40%
- Q2 2022: 35%
- Q3 2022: 38%
- Q4 2022: 42%
- Q1 2023: 43%
- Q2 2023: 37%
- Q3 2023: 43%
- Q4 2023: 40%
- Q1 2024: 41%
- Q2 2024: 41%
- Q3 2024: 39%
- Q4 2024: 36%
- Q1 2025: 34%
- Q2 2025: 31%
- Q3 2025: 34%
- Q4 2025: 35%
- Q1 2026: 35%
- Q2 2026: 36%
The positions that defined it
Every position that was ever among the 25 largest: when it first appeared, when it was largest, and where it stands in Q2 2026. The line is its reported value each quarter.
| Position | Value over time | First listed | Largest | Q2 2026 |
|---|---|---|---|---|
| Visa Inc(V)Common Class A | Q2 2013 | $2.2bnQ2 2026 | $2.2bn | |
| Taiwan Semiconductor MFG LTD(TSM)Sponsored ADS | Q3 2020 | $1.5bnQ2 2026 | $1.5bn | |
| Air Prods & Chems Inc(APD) | Q3 2014 | $1.4bnQ2 2026 | $1.4bn | |
| Sherwin Williams Co(SHW) | Q3 2013 | $1.3bnQ2 2026 | $1.3bn | |
| Fortive Corp(FTV) | Q3 2019 | $1.2bnQ1 2026 | $1.2bn | |
| Facebook Inc(META)Class A | Q3 2013 | $2.4bnQ3 2016 | $1.1bn | |
| Schwab Charles Corp New(SCHW) | Q4 2016 | $1.6bnQ3 2025 | $982m | |
| Thermo Fisher Scientific Inc(TMO) | Q2 2013 | $1.2bnQ1 2014 | $971m | |
| JPMorgan Chase & Co(JPM) | Q1 2017 | $1.8bnQ4 2024 | $949m | |
| Lennox Intl Inc(LII) | Q4 2025 | $912mQ2 2026 | $912m | |
| Amazon Com Inc(AMZN) | Q2 2015 | $2.5bnQ3 2016 | $882m | |
| Ferrari N V(RACE) | Q3 2018 | $817mQ2 2026 | $817m | |
| Ginkgo Bioworks Holdings IncClass A Shares | Q3 2021 | $3.9bnQ3 2021 | Soldlast listed Q2 2024 | |
| Walgreens Boots Alliance Inc | Q4 2014 | $2.1bnQ2 2015 | Soldlast listed Q2 2021 | |
| Allergan PLC | Q2 2015 | $2.1bnQ2 2015 | Soldlast listed Q1 2017 | |
| Broadcom CorpClass A | Q4 2014 | $2.0bnQ4 2015 | Soldlast listed Q4 2015 | |
| Actavis PLC | Q4 2013 | $1.8bnQ1 2015 | Soldlast listed Q1 2015 | |
| Anthem Inc(ELV) | Q4 2014 | $1.8bnQ1 2019 | Soldlast listed Q2 2023 | |
| Teva Pharmaceutical Inds LTD(TEVA)ADR | Q1 2015 | $1.8bnQ1 2016 | Soldlast listed Q3 2016 | |
| General Electric Co(GE) | Q3 2021 | $1.7bnQ3 2021 | Soldlast listed Q1 2024 |
Quarter by quarter
Q3 2015: $26.1bn across 63 positions
Against Q2 2015: 23 new, 19 added to, 21 trimmed, 16 sold out, across all 63 positions.
Turnover about 23% of the book, estimated from share changes at quarter-end prices.
Largest additions
- Amazon Com Inc (AMZN)+$554m
- Anthem Inc (ELV)+$515m
- Mckesson Corp (MCK)+$280m
- Avago Technologies LTD+$234m
- Allstate Corp (ALL)+$197m
- Transdigm Group Inc (TDG)+$139m
- Kite Pharma Inc+$96m
- American Intl Group Inc (AIG)+$79m
Largest reductions
- Illumina Inc (ILMN)-$770m
- Mohawk Inds Inc (MHK)-$463m
- Mallinckrodt Pub LTD Co-$387m
- Alibaba Group HLDG LTD (BABA)-$351m
- Mastercard Inc (MA)-$279m
- Whiting Pete Corp New-$275m
- Sealed Air Corp New (SEE)-$256m
- Canadian Pac Ry LTD-$248m
Opened
- Broadcom Corp$1.2bn
- Laboratory Corp Amer HLDGS$548m
- Teva Pharmaceutical Inds LTD (TEVA)$501m
- Netflix Inc (NFLX)$466m
Sold out
- Metlife Inc (MET)was $660m
- Cigna Corporationwas $472m
- Twenty First Centy Fox Incwas $263m
- Baidu Inc (BIDU)was $256m
- Receptos Incwas $220m
- Biogen Idec Inc (BIIB)was $207m
- Aon PLCwas $191m
- Avis Budget Group (CAR)was $190m
Largest positions, Q3 2015
The largest 25 of 63 reported positions.
| Position | Value | Weight | On the quarter |
|---|---|---|---|
| Allergan PLC | $2.0bn | 7.5% | Added |
| Walgreens Boots Alliance Inc | $1.9bn | 7.4% | Trimmed |
| Google Inc | $1.6bn | 6.2% | Trimmed |
| Amazon Com Inc (AMZN) | $1.5bn | 5.9% | Added |
| Broadcom Corp | $1.2bn | 4.6% | New |
| Lyondellbasell Industries N (LYB) | $1.1bn | 4.3% | Added |
| Valeant Pharmaceuticals Intl | $891m | 3.4% | Added |
| Avago Technologies LTD | $868m | 3.3% | Added |
| Anthem Inc (ELV) | $828m | 3.2% | Added |
| Pioneer Nat Res Co | $811m | 3.1% | Added |
| Air Prods & Chems Inc (APD) | $755m | 2.9% | Added |
| Humana Inc (HUM) | $690m | 2.6% | Added |
| Google Inc | $682m | 2.6% | Trimmed |
| Cheniere Energy Inc (LNG) | $631m | 2.4% | Added |
| Canadian Pac Ry LTD | $597m | 2.3% | Trimmed |
| Laboratory Corp Amer HLDGS | $548m | 2.1% | New |
| Teva Pharmaceutical Inds LTD (TEVA) | $501m | 1.9% | New |
| Mastercard Inc (MA) | $489m | 1.9% | Trimmed |
| Netflix Inc (NFLX) | $466m | 1.8% | New |
| Mckesson Corp (MCK) | $421m | 1.6% | Added |
| Bank New York Mellon Corp (BNY) | $403m | 1.5% | Added |
| Sealed Air Corp New (SEE) | $402m | 1.5% | Trimmed |
| Aetna Inc New | $381m | 1.5% | Added |
| Envision Healthcare HLDGS In | $363m | 1.4% | Trimmed |
| Mohawk Inds Inc (MHK) | $360m | 1.4% | Trimmed |
The books most like this one
Among the managers whose filings are on file, at Q2 2026. Overlap is the share of the two books that is the same: for every stock both list, the smaller of its two weights, added up. Two books can overlap because both own the largest companies; it says nothing about whether the managers agree.
| Manager | Overlap | Stocks in both | Overlap over time | |
|---|---|---|---|---|
| Maverick Capital Ltd | 21% | 18 | Compare | |
| Dodge & Cox | 20% | 24 | Compare | |
| Capital World Investors | at least 17% | 39 | Compare | |
| MFS Investment Management | at least 16% | 36 | Compare | |
| Tiger Global Management LLC | 16% | 10 | Compare | |
| Polen Capital Management LLC | 16% | 16 | Compare | |
| Capital Research Global Investors | 15% | 36 | Compare | |
| T. Rowe Price Associates Inc | at least 15% | 41 | Compare |
“At least” where either manager has more positions than are read each quarter: a stock both hold below that range is not counted.
The filings behind it
Every quarter above is one 13F holdings report, with any amendment the filer made to it applied in the order it was filed. Where the reporting entity changed, each quarter keeps the filer that actually reported it.
| Quarter | Filer | Book | Amended | Filing |
|---|---|---|---|---|
| Q2 2026 | Viking Global Investors LP | $35.1bn | 13F-HR | |
| Q1 2026 | Viking Global Investors LP | $35.7bn | 13F-HR | |
| Q4 2025 | Viking Global Investors LP | $37.7bn | 13F-HR | |
| Q3 2025 | Viking Global Investors LP | $38.5bn | 13F-HR | |
| Q2 2025 | Viking Global Investors LP | $34.6bn | 13F-HR | |
| Q1 2025 | Viking Global Investors LP | $31.5bn | 13F-HR | |
| Q4 2024 | Viking Global Investors LP | $30.9bn | 13F-HR | |
| Q3 2024 | Viking Global Investors LP | $27.4bn | 13F-HR | |
| Q2 2024 | Viking Global Investors LP | $26.0bn | 13F-HR | |
| Q1 2024 | Viking Global Investors LP | $26.9bn | 13F-HR | |
| Q4 2023 | Viking Global Investors LP | $27.3bn | 13F-HR | |
| Q3 2023 | Viking Global Investors LP | $24.6bn | 13F-HR | |
| Q2 2023 | Viking Global Investors LP | $24.4bn | 13F-HR | |
| Q1 2023 | Viking Global Investors LP | $21.3bn | 13F-HR | |
| Q4 2022 | Viking Global Investors LP | $20.0bn | 13F-HR | |
| Q3 2022 | Viking Global Investors LP | $21.7bn | 13F-HR | |
| Q2 2022 | Viking Global Investors LP | $21.9bn | 13F-HR | |
| Q1 2022 | Viking Global Investors LP | $24.7bn | 13F-HR | |
| Q4 2021 | Viking Global Investors LP | $34.7bn | 13F-HR | |
| Q3 2021 | Viking Global Investors LP | $36.5bn | 13F-HR | |
| Q2 2021 | Viking Global Investors LP | $33.0bn | 13F-HR | |
| Q1 2021 | Viking Global Investors LP | $33.6bn | 13F-HR | |
| Q4 2020 | Viking Global Investors LP | $36.4bn | 13F-HR | |
| Q3 2020 | Viking Global Investors LP | $27.7bn | 13F-HR | |
| Q2 2020 | Viking Global Investors LP | $23.1bn | 13F-HR | |
| Q1 2020 | Viking Global Investors LP | $19.2bn | 13F-HR | |
| Q4 2019 | Viking Global Investors LP | $21.4bn | 13F-HR | |
| Q3 2019 | Viking Global Investors LP | $19.2bn | 13F-HR | |
| Q2 2019 | Viking Global Investors LP | $22.3bn | 13F-HR | |
| Q1 2019 | Viking Global Investors LP | $17.4bn | 13F-HR | |
| Q4 2018 | Viking Global Investors LP | $17.6bn | 13F-HR | |
| Q3 2018 | Viking Global Investors LP | $18.1bn | 13F-HR | |
| Q2 2018 | Viking Global Investors LP | $17.5bn | 13F-HR | |
| Q1 2018 | Viking Global Investors LP | $16.6bn | 13F-HR | |
| Q4 2017 | Viking Global Investors LP | $16.3bn | 13F-HR | |
| Q3 2017 | Viking Global Investors LP | $15.4bn | 13F-HR | |
| Q2 2017 | Viking Global Investors LP | $14.8bn | 13F-HR | |
| Q1 2017 | Viking Global Investors LP | $22.6bn | 13F-HR | |
| Q4 2016 | Viking Global Investors LP | $22.0bn | 13F-HR | |
| Q3 2016 | Viking Global Investors LP | $23.2bn | 13F-HR | |
| Q2 2016 | Viking Global Investors LP | $23.5bn | 13F-HR | |
| Q1 2016 | Viking Global Investors LP | $22.7bn | 13F-HR | |
| Q4 2015 | Viking Global Investors LP | $26.5bn | 13F-HR | |
| Q3 2015 | Viking Global Investors LP | $26.1bn | 13F-HR | |
| Q2 2015 | Viking Global Investors LP | $26.5bn | 13F-HR | |
| Q1 2015 | Viking Global Investors LP | $25.8bn | 13F-HR | |
| Q4 2014 | Viking Global Investors LP | $21.8bn | 13F-HR | |
| Q3 2014 | Viking Global Investors LP | $24.9bn | 13F-HR | |
| Q2 2014 | Viking Global Investors LP | $22.9bn | 13F-HR | |
| Q1 2014 | Viking Global Investors LP | $23.8bn | 13F-HR | |
| Q4 2013 | Viking Global Investors LP | $21.4bn | 13F-HR | |
| Q3 2013 | Viking Global Investors LP | $18.1bn | 13F-HR | |
| Q2 2013 | Viking Global Investors LP | $18.0bn | 13F-HR |
Reading this record
A 13F lists US-listed long equity and options at the quarter end, filed up to 45 days later. It shows what was held, not when it was bought or at what price, and nothing short. Where a quarter lists only the largest positions, a name missing from it may still be held below that range; the counts of what was opened and sold always cover the whole filing.
Company names, tickers and logos are the trademarks of their respective owners and appear here to identify the company whose public figures are being used. L3VLUP is not affiliated with, sponsored by or endorsed by any company shown, and nothing here is a statement by or about that company. More